Medplus Health Services Ltd
Medplus Health Services Ltd (MEDPLUS) last traded at ₹680, a market capitalisation of ₹8,171 crore, on a P/E of 38.8. Over the past 52 weeks the stock has ranged between ₹647 and ₹1,022. Medplus Health Services Ltd last reported results for the quarter ended Jun 2026, with sales of ₹1,880 crore and net profit of ₹33 crore. Figures are as of 25 Aug 2026 and are not real time.
Medplus Health Services Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Medplus Health Services Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹1,880 cr, up 21.8% from ₹1,543 cr a year earlier. Net profit was ₹33 cr, down 21.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,576 | 1,561 | 1,510 | 1,543 | 1,679 | 1,806 | 1,864 | 1,880 |
| Expenses | 1,452 | 1,429 | 1,373 | 1,412 | 1,530 | 1,648 | 1,695 | 1,746 |
| Operating profit | 124 | 133 | 136 | 131 | 149 | 159 | 169 | 133 |
| OPM % | 8% | 8% | 9% | 8% | 9% | 9% | 9% | 7% |
| Other income | 12 | 13 | 16 | 15 | 17 | 18 | 21 | 20 |
| Interest | 25 | 26 | 27 | 27 | 29 | 31 | 33 | 33 |
| Depreciation | 63 | 62 | 64 | 66 | 69 | 73 | 76 | 78 |
| Profit before tax | 48 | 57 | 61 | 53 | 69 | 73 | 80 | 42 |
| Tax % | 19% | 19% | 16% | 20% | 19% | 21% | 20% | 21% |
| Net profit | 39 | 46 | 51 | 42 | 56 | 58 | 64 | 33 |
| EPS (₹) | 3.24 | 3.83 | 4.29 | 3.54 | 4.63 | 4.82 | 5.33 | 2.76 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Medplus Health Services Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 3,069 | 3,779 | 4,558 | 5,625 | 6,136 | 6,892 | 7,229 |
| Operating profit | 217 | 273 | 266 | 355 | 488 | 608 | 610 |
| OPM % | 7% | 7% | 6% | 6% | 8% | 9% | 8% |
| Net profit | 63 | 95 | 50 | 66 | 150 | 220 | 210 |
| EPS (₹) | 1,393.11 | 8.03 | 4.17 | 5.48 | 12.56 | 18.30 | 17.54 |
TTM is the trailing twelve months to the most recent quarter.
Medplus Health Services Ltd growth and returns
- 10 Years
- 15%
- 5 Years
- 18%
- 3 Years
- 15%
- TTM
- 17%
- 10 Years
- 37%
- 5 Years
- 28%
- 3 Years
- 66%
- TTM
- 18%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -9%
- 1 Year
- -20%
- 10 Years
- 8%
- 5 Years
- 7%
- 3 Years
- 8%
- Last Year
- 12%
Medplus Health Services Ltd shareholding pattern
Promoters held 40.19% at Jun 2026, broadly unchanged since Jun 2025. FIIs 14.38% and DIIs 29.95%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 40.39% | 40.39% | 40.33% | 40.32% | 40.29% | 40.29% | 40.22% | 40.19% |
| FIIs | 14.72% | 15.23% | 15.61% | 16.43% | 16.53% | 16.83% | 15.53% | 14.38% |
| DIIs | 27.98% | 25.66% | 26.19% | 26.03% | 26.51% | 26.58% | 27.82% | 29.95% |
| Public | 16.85% | 18.68% | 17.82% | 17.18% | 16.60% | 16.27% | 16.41% | 15.45% |
| No. of shareholders | 87,328 | 83,912 | 83,439 | 81,742 | 78,337 | 79,157 | 77,278 | 76,005 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Medplus Health Services Ltd corporate filings
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship LtdInsider Trading / SASTmedium impact
Cruxal's analysis: MedPlus Health Services Limited has reported a pledge of 62.51 lakh equity shares…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual FundInsider Trading / SASTmedium impact
Cruxal's analysis: ICICI Prudential Mutual Fund has increased its shareholding in Medplus Health Services…
Read the full analysis - Submission of Voting results Along with Scrutinizer''s Report of the 20th Annual General Meeting of the company.AGM/EGMlow impact
Cruxal's analysis: MedPlus Health Services Limited has successfully concluded its 20th Annual General…
Read the full analysis - Summary Proceedings of 20th Annual General Meeting of the Company held on August 17, 2026AGM/EGMlow impact
Cruxal's analysis: MedPlus Health Services Limited has successfully concluded its 20th Annual General…
Read the full analysis - Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Company Updatelow impact
Cruxal's analysis: Medplus Health Services Ltd has submitted a routine disclosure under Regulation 30 of the…
Read the full analysis - Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Company Updatelow impact
Cruxal's analysis: Medplus Health Services Ltd has submitted a routine disclosure under Regulation 30 of the…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Medplus Health Services Ltd
Cruxal reads every Medplus Health Services Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.